Abstract : Rabbits were divided to groups of 3, and injected either 9.9 mg of tetramethyllead (Me4Pb)/kg of body weight (7.7 mg Pb/kg) or 39.7 mg/kg (30.8 mg Pb/kg) into the ear vein once only, respectively, and urinary and fecal excretions of lead were studied for chemical species and total lead during the following 7 days.
INTRODUCTION
Tetramethyllead (Me4Pb) is a tetraalkyllead compound developed and produced as an antiknock for use on gasoline engines, and like tetraethyllead (Et4 Pb), is used as a mixture with gasoline. Environmental contamination with lead, however, created social problems, and along with the self-controlled restriction of use of lead-containing gasoline in the western Europe and north America as well as in Japan, the consumption of tetraalkyllead also decreased. In the countries In the urine of human subjects exposed to Et4Pb, triethyllead (Et3Pb+), diethyllead (Et2Pb2+) and inorganic lead (Pb2+) are excreted, with Et2Pb2+ accounting for about a half of the total lead excretion. 4, 5) Experiments in rabbits gave similar results.6,7) These findings demonstrated that urinary Et2Pb' would be a specific indicator of occupational Et4Pb exposure. 7, 8) Me4Pb, like Et4Pb, is metabolized in vivo to form trialkyllead.3,9) According to Gething and Oxley,11) Birnie and Hodges (1978)10) examined Me4Pb-exposed workers, and found that trimethyllead (Me3Pb+) accounted for about 21%, and Pb2+, for the rest of the urinary total lead excretion.
In their experiments in rats, Cremer and Callaway3) injected Me4Pb into the caudal vein of rats, and detected Me3Pb+ in the blood, liver and kidneys of the rats at 4 and 24 hours after the injection. They reported that Me3Pb+ was more toxic than Me4Pb, revealing that trialkyllead is strongly toxic as is Et3Pb+.
In the present study, we administered Me4Pb into the ear vein of rabbits once only, and studied the chemical species of lead excreted in the urine and feces and the total lead excretion. The lead contents of these 3 lead compounds proved to be 99-98% of the respective theoretical lead contents. Me4Pb contained only not more than 0.006% Me3Pb+ and Me2Pb2+, respectively, and also not more than 0.03% Pb2+.
MATERIALS AND METHODS

Reagents
The trimethyllead chloride contained 0.04% Me4Pb and 0.01% Me2Pb2+, but only not more than 0.03% Pb2+. The standard solution of Me2Pb2+ contained only not more than 0.8% Me4Pb, Me3Pb+ and Pb2+, respectively. Glyoxal-bis(2-hydroxyanil) solution14) (GHA solution) : The GHA solution was prepared by dissolving 0.24 g of dotite GHA (Dojindo Co., Ltd., Kumamoto, Japan) in 100 ml of methanol.
Nitric acid, perchloric acid, ammonium hydroxide, sodium diethyldithiocarbamate (SDDC), and methyl isobutyl ketone (MIBK) of the quality of "reagent for poisonous metals analysis" were used, and the other reagents used were of the quality of special class or higher. The dose of 9.9 mg of Me4Pb/kg contained the same amount of lead as the dose of 12 mg of Et4Pb/kg used in a previous study.6) This dose of 12 mg of Et 4Pb/kg was equivalent to about 2/3 of its lowest published lethal dose to rabbits (18.5 mg/kg).
The dose of 39.7 mg of Me4Pb/kg was about 4 times as large as the dose of 9.9 me/ka.
After the injection of Me4Pb, the rabbits were maintained on water and a feed in metabolic cages for 7 days, and during this period, the urine and feces were collected every day. At 7 days after the injection, the rabbits were killed to measure the lead contents in organs.
Procedures for determination
A partial modification of our method15) for the determination of urinary Et3 Pb+, Et2Pb2+, and Pb2+ was used for the determination of urinary Me4Pb, Me3 Pb+, and Me2Pb2+.
To a separating funnel, 40 ml of each urine sample was transferred;
Me4Pb, Me3Pb+ and Me2Pb2+ were sequentially extracted into MIBK, and assayed by flame atomic absorption spectrometry (AAS). (Fig. 1B) . EDTA-2Na-containing and EDTA-2Na-free urine samples were assayed for Pb2+, and the differences between the assays were calculated as actua] measurements of urinary Pb2+. For the determination of urinary total lead, 10 ml of each urine sample was transferred into a Teflon decomposition vessel, decomposed by heating in 5 ml of concentrate HNO3 under increased pressure, extracted into organic solvents (SDDC+ MIBK), and assayed by AAS. For the determination of Me4Pb, Me3Pb+, Me2Pb2+, and Pb2+ in the feces, blood, bile and organs, about 1 g of each sample was weighed into a polypropylene, stoppered, centrifuge tube, and after the addition of 20 ml of redistilled water, treated in a manner similar to urine samples.
For the extraction of Me3 Pb+, however, 5 ml of 60% HC104 was added (Fig. 1C) .
For the determination of total lead in the feces, blood, bile and organs, aboul 0.5 g of each sample was transferred into a Teflon decomposition vessel, and then treated in a fashion similar to urine samples.
For the determination of lead in the bone, 8 ml of 1 M diammonium hydrogen citrate was added instead of 1 ml to the solution after thermal decomposition.
In calculating the lead weight % of each chemical species to total lead excretion, the sum of Me4Pb, Me3Pb+, Me2Pb2+, and Pb2+ excretions was used in place of actual measurement. After 20,ug as Pb of each of the chemical species was added to 1 g of a rabbit feces sample, the mixture was assayed, and a recovery rate of 89-99% was achieved.
After the same amount of each of the chemical species of lead was added to 1 g of a rabbit liver sample, the mixture was assayed, and a recovery rate of 91-99% was achieved. Table 2 [A] shows the % ratios of urinary and fecal total lead excretions to the administered dose of lead in the group injected 9.9 mg of Me4Pb/kg. The urinary total lead excretion during 7 days after the injection amounted to about 1% of the administered dose of lead, and about 70% of the excretion occurred on the day following the injection. The fecal total lead excretion during the 7 days amounted to about 8% of the administered dose of lead. Table 2 [B] shows the % ratios of urinary and fecal total lead excretions to the administered dose of lead in the group injected 39.7 mg of Me4Pb/kg. The urinary total lead excretion amounted to about 2% of the administered dose of lead during 7 days after the injection, and about 50% of the excretion occurred on the day after the injection. The fecal total lead excretion during the 7 days amounted to about 14% of the administered dose of lead. for Pb2+, and the actual measurement was obtained from the differences.
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The % ratios of urinary and fecal total lead excretions to the administered dose of lead for the group injected 39.7 mg of Me4Pb/kg were slightly greater than those for the group injected 9.9 mg/kg. Chemical species of urinary and fecal leads Figure 2 [A] shows the daily urinary excretion of each chemical species of lead on Days 1-7 after the injection of 9.9 mg of Me4Pb/kg. The urinary total lead Seven days after the injection, about 9% of the administered dose of lead was retained in the liver, about 0.3% in the kidneys, and about 0.01% in the brain. Table 4 shows the contents of each chemical species of lead in the organs of rabbits killed 7 days after the injection of 39.7 mg of Me4Pb/kg. The total lead content in the liver was composed of about 89% Me3Pb+, about 4% Me2Pb2+ and about 7% Pb2+. The content in the kidney was composed of about 85% Me 3Pb+ and about 15% Pb2+. The content in the brain was composed of about 87% Me3Pb+ and 13% Pb2+. No Me4Pb was detected in any Organs.
Seven days after the injection, about 4% of the administered dose of lead was retained in the liver, about 0.2% in the kidneys, and about 0.02% in the brain. DISCUSSION Gething (1975) reported a worker who, after an accidental exposure of the whole body to Me4Pb at an Me4Pb plant, excreted high levels of lead in the urine during the ensuing few days1) This report suggested that some watersoluble organic lead might have been excreted in the urine.
According to Gething and Oxley,11) Birnie and Hodges10) in 1978 investigated urine samples from workers engaged in the production of Me4Pb, and reported that Me3P13+ accounted for about 21%, and Pb2+, for the rest of urinary total lead excretion. As the data is not published, no more details are known.
In Et4Pb poisoning, the urinary total lead excretion is greater than in inorganic lead poisoning. [17] [18] [19] . The urinary total lead is composed of a large percentage of Et2Pb2+. In a previous paper,4) we reported that the total lead excretion in the urine of a patient with Et4Pb poisoning was composed of about 50% Et2Pb2+, about 48% Pb2+, and about 2% Et3Pb+ 21 days after exposure to Et4Pb.
Turlakiewicz et al.5) reported that they examined 3 lead poisoning patients who were admitted after drinking Et4Pb, and that the urinary total lead excretion was composed of 31-90% Et2Pb2+. Turlakiewicz and Chmielnicka8) examined urine samples from 26 workers exposed to Et4Pb, and found that there was an intimate correlation between ambient Et4Pb concentrations and urinary Et2Pb2+ concentrations, and that Et2Pb2+ would be a specific indicator of occupational Et4Pb exposure. In a study in rabbits injected Et4Pb intravenously, the urinary total lead excretion 1 day after the injection was composed of about 69% Et2Pb2+, about 27% Pb2+ and about 4% Et3Pb+.6) From their experiments by intravenous and intraperitoneal administration of Et4Pb to rabbits, Kozarzewska and Chmielnicka7) reported that the urinary total lead excretion 1 day after either injection was composed of 65-90% Et2P132+.
In the present study by intravenous injection of Me4Pb to rabbits, the urinary Me2Pb2+ excretion amounted to about 70% of the urinary total lead excretion on the day following the injection, but decreased to about 10% 7 days after the injection, whereas the urinary Me3Pb+ excretion amounted to about 20% of the urinary total lead excretion on the day following the injection, but increased to about 70% 7 days after the injection.
Et4Pb is metabolized to Et3Pb+ by the catalytic activity of monooxygenase of the cytochrome P-450 systems.19-21) The degradation of Et3Pb+ to Et2Pb2+ and that of Et2Pb2+ to Pb2+ appear to result from the dealkylation of the species of lead in disproportionation. 19) The metabolism of Me4Pb, on the other hand, is thought to differ from that of Et4Pb because the former probably does not undergo beta-oxidation. 19, 22) In biological monitoring of Et4Pb exposure, urinary Et2Pb2+ is a good indicator, 7, 8, 19) while it is not adequate to choose urinary Me2Pb2+ as an indicator of Me4Pb exposure, because the urinary Me2Pb2+ excretion occurred mostly at early stages after the administration of Me4Pb, and the urinary Me2Pb2+ excretion was practically undetectable 7 days after the administration.
The urinary Me3Pb+ excretion, on the other hand, continued to be high from 1 through 7 days after the administration of Me4Pb. Urinary Me3Pb+ can therefore be a good indicator of occupational Me4Pb exposure.
The urinary total lead excretion during the 7 days following the administration of Me4Pb amounted to about 1% of the administered dose of lead in the group injected 9.9 mg of Me4Pb/kg (7.7 mg Pb/kg), and the fecal total lead excretion, to about 8 % of the administered dose of lead.
In a previous study by administration of Et4Pb in the same dose of lead (7.7 mg Pb/kg) to rabbits,6) the urinary total lead excretion during the 7 days following the administration amounted to about 4% of the administered dose of lead, and the fecal total lead excretion, to about 56% of the administered dose.
In other words, there was practically no difference in the urinary total lead excretion between the Me4Pb-treated and the Et4Pb-treated rabbits, but the fecal total lead excretion was extremely smaller in the former.
This small fecal excretion of total lead appeared to have derived from the less elimination of lead into the bile.
